Clifford A. Hudis - Concepedia

Author

Clifford A. Hudis

Memorial Sloan Kettering Cancer Center ORCID

Also Known As

A Hudis Clifford, Atkins, James N., Barry, William T., Berry, Donald A., C A Hudis, C Hudis, C. A. Hudis, C. Hudis, C.A. Hudis, CLIFFORD A. HUDIS

939

Publications

80.9K

Citations

126

H-Index

246

Concepts

All Affiliations

Memorial Sloan Kettering Cancer Center Dana-Farber Cancer Institute Cornell University The University of Texas MD Anderson Cancer Center University of North Carolina at Chapel Hill

About

Clifford A. Hudis is an author at Memorial Sloan Kettering Cancer Center specializing in medicine, breast cancer, and oncology.

Top Concepts

#	Concept	H-Index	Publications	Citations
1	Health Sciences	30	43	6.8K
2	Engineering	2	2	78
3	Arts	1	1	120
4	Education	1	1	105
5	Management	1	1	24

Clifford A. Hudis

376

Publications

66.8K

Citations

116

H-Index

Page 1

	Year	Citations
Personalizing the treatment of women with early breast cancer: highlights of the St Gallen International Expert Consensus on the Primary Therapy of Early Breast Cancer 2013 Aron Goldhirsch, Eric P. Winer, Alan S. Coates, Annals of Oncology Surgical OncologyBreast OncologyCancer ManagementPrimary TherapyPathology	2013	3.6K
Symptom Monitoring With Patient-Reported Outcomes During Routine Cancer Treatment: A Randomized Controlled Trial Ethan Basch, Allison M. Deal, Mark G. Kris, Journal of Clinical Oncology	2015	2.5K
3rd ESO–ESMO International Consensus Guidelines for Advanced Breast Cancer (ABC 3) Fátima Cardoso, A. Costa, Elżbieta Senkus, Annals of Oncology	2016	2.1K
Tailoring therapies—improving the management of early breast cancer: St Gallen International Expert Consensus on the Primary Therapy of Early Breast Cancer 2015 Alan S. Coates, Eric P. Winer, Aron Goldhirsch, Annals of Oncology	2015	1.8K
Randomized Trial of Dose-Dense Versus Conventionally Scheduled and Sequential Versus Concurrent Combination Chemotherapy as Postoperative Adjuvant Treatment of Node-Positive Primary Breast Cancer: First Report of Intergroup Trial C9741/Cancer and Leukemia Group B Trial 9741 Marc L. Citron, Donald A. Berry, Constance Cirrincione, Journal of Clinical Oncology	2003	1.6K
Cardiac Dysfunction in the Trastuzumab Clinical Trials Experience Andrew D. Seidman, Clifford A. Hudis, Mary Kathryn Pierri, Journal of Clinical Oncology	2002	1.5K
Phase II study of weekly intravenous recombinant humanized anti-p185HER2 monoclonal antibody in patients with HER2/neu-overexpressing metastatic breast cancer. José Baselga, Debu Tripathy, John Mendelsohn, Journal of Clinical Oncology	1996	1.4K
Prognostic and predictive value of the 21-gene recurrence score assay in postmenopausal women with node-positive, oestrogen-receptor-positive breast cancer on chemotherapy: a retrospective analysis of a randomised trial Kathy S. Albain, William E. Barlow, Steven Shak, The Lancet Oncology 21-Gene Recurrence ScoreBreast OncologyMedicineRandomised TrialPathology	2009	1.4K
Lumpectomy Plus Tamoxifen With or Without Irradiation in Women Age 70 Years or Older With Early Breast Cancer: Long-Term Follow-Up of CALGB 9343 Kevin S. Hughes, Lauren A. Schnaper, Jennifer R. Bellon, Journal of Clinical Oncology	2013	1.3K
Risk-Reducing Salpingo-oophorectomy in Women with a<i>BRCA1</i>or<i>BRCA2</i>Mutation Noah D. Kauff, Jaya M. Satagopan, Mark E. Robson, New England Journal of Medicine	2002	1.2K

Page 1